Amanta Healthcare Makes Steady Market Debut; Lists At 7% Premium

Published : Sep 09, 2025, 11:30 AM IST
https://stocktwits.com/news-articles/markets/equity/amanta-healthcare-makes-steady-market-debut-lists-at-7-premium-over-issue-price/chw0sjURdsP

Synopsis

The stock listed at ₹135 per share on the NSE and ₹134 on the BSE.

Amanta Healthcare shares made a firm debut in the benchmark indices on Tuesday. The stock listed at ₹135 per share on the NSE, marking a 7.14% premium over its issue price of ₹126. On the BSE, it opened at ₹134, up 6.35% from the issue price.

The listing performance was in line with street expectations, as suggested by the grey market premium (GMP) of ₹9 per share.   

Subscription Details

The bidding for the Amanta Healthcare IPO opened on September 1 and closed on September 3, with allotment being finalized on September 4. Through the public issue, the company raised ₹126 crore via a fresh issue of 1 crore equity shares. The price band for the IPO was fixed in the range of ₹120 - ₹126 per share.

Investor interest in the issue was strong across all classes, with an overall subscription of 82.61 times, according to NSE data. The retail category saw subscription of 54.98 times, while the Non-Institutional Investors (NII) segment was heavily oversubscribed at 209.42 times. The Qualified Institutional Buyers (QIBs) category recorded a subscription of 35.86 times.

Beeline Capital Advisors acted as the book-running lead manager for the issue, and MUFG Intime India served as the registrar.

Amanta Healthcare develops sterile liquid products, with a primary focus on parenteral solutions.

For updates and corrections, email newsroom[at]stocktwits[dot]com. <

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Read more Articles on

Recommended Stories

Walmart, Target Face FDA Heat After Recalled Baby Formula Tied To Infant Botulism Found In Stores
Costco Stock Heads For Worst Day In A Month On Rare Sell Call — Jim Cramer Rings The Valuation Alarm